NYSE
$251.88▼ 0.02%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $10.39BShares out 41.3M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
4- 3d agoAfter-hours26.10.22 05:308-KKey event#●●●
Evercore Inc.
Evercore has appointed Nigel Dawn and Naveen Nataraj as Co-Presidents, effective January 1, 2027. Each appointee will receive a one-time award of Performance Restricted Stock Units (PRSUs) with a target value of $20 million, subject to the achievement of operating income and shareholder return goals over a three-year period.…more
$251.88-0.02%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.5After-hours26.08.06 05:0710-QEarnings
Evercore Inc.
에버코어(Evercore Inc.)는 2026년 2분기 분기 보고서(10-Q)를 통해 재무 상태와 경영 성과를 공시했습니다. 해당 보고서에는 최고경영자(CEO)와 최고재무책임자(CFO)의 재무제표 및 내부 통제 시스템에 대한 공식 인증이 포함되었습니다.…more
$251.88-0.02%vs prev closeView filingShare - 7.31Regular26.08.01 00:21SCHEDULE 13GOwnership
Evercore Inc.
뱅가드 포트폴리오 매니지먼트(Vanguard Portfolio Management LLC)가 에버코어(Evercore Inc.)의 지분 5% 이상을 보유한 주요 주주로 공시되었습니다. 이는 기관 투자자의 대량 지분 확보를 의미하며, 해당 기업에 대한 투자 비중 변화를 나타냅니다.…more
$251.88-0.02%vs prev closeView filingShare
3 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 6d agoPre-market26.10.19 21:43#●●●
Goldman, Evercore Pitching 'Forever Funds' to Private Equity
Goldman Sachs and Evercore are actively pitching 'forever fund' structures to private equity firms to eliminate fixed capital recycling timelines. This shift aims to move away from traditional closed-end models toward more flexible, long-term asset management strategies.…more
$251.88-0.02%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 6d agoOvernight26.10.19 16:08
●●●●●●●● ●●●●● ●●●●●●
Evercore announced that Nigel Dawn and Naveen Nataraj will serve as co-presidents starting January 1, 2027. John Weinberg will continue to serve as chairman and CEO for at least three more years.…more
$251.88-0.02%vs prev closeShareBenzinga - 10.16Overnight26.10.16 14:19
●●●●●●●● ●●●●● ●●●●●●
Recursion Pharmaceuticals has raised $200 million through a stock offering priced at $3.25 per share. Additionally, the company secured a $10 million milestone payment after Sanofi selected a candidate from their collaborative research program.…more
$251.88-0.02%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report